These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1009 related items for PubMed ID: 25985912

  • 1. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q, Liu J, Zhu W, Sun C, Di D, Zhang Y, Wang P, Wang Z, Wang S.
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M, Jambhrunkar S, Thorn P, Chen J, Gu W, Yu C.
    Nanoscale; 2013 Jan 07; 5(1):178-83. PubMed ID: 23076766
    [Abstract] [Full Text] [Related]

  • 3. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q, Geng H, Wang Y, Gao Y, Huang J, Wang Y, Zhang J, Wang S.
    ACS Appl Mater Interfaces; 2014 Nov 26; 6(22):20290-9. PubMed ID: 25311422
    [Abstract] [Full Text] [Related]

  • 4. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J, Sun Y, Tian B, Li K, Wang L, Liang Y, Han J.
    Colloids Surf B Biointerfaces; 2016 Aug 01; 144():293-302. PubMed ID: 27107383
    [Abstract] [Full Text] [Related]

  • 5. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y, Cui Y, Zhao Y, He B, Shi X, Di D, Zhang Q, Wang S.
    Eur J Pharm Biopharm; 2017 Aug 01; 117():105-115. PubMed ID: 28363599
    [Abstract] [Full Text] [Related]

  • 6. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy.
    Lu J, Luo B, Chen Z, Yuan Y, Kuang Y, Wan L, Yao L, Chen X, Jiang B, Liu J, Li C.
    Int J Biol Macromol; 2020 Mar 01; 146():363-373. PubMed ID: 31911174
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging.
    Zhao Q, Wang S, Yang Y, Li X, Di D, Zhang C, Jiang T, Wang S.
    Mater Sci Eng C Mater Biol Appl; 2017 Sep 01; 78():475-484. PubMed ID: 28576012
    [Abstract] [Full Text] [Related]

  • 8. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
    Han N, Zhao Q, Wan L, Wang Y, Gao Y, Wang P, Wang Z, Zhang J, Jiang T, Wang S.
    ACS Appl Mater Interfaces; 2015 Feb 11; 7(5):3342-51. PubMed ID: 25584634
    [Abstract] [Full Text] [Related]

  • 9. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S, Huai J, Chen X, Yang Y, Zhang X, Gan Y, Wang G, Gu X, Li J.
    Acta Biomater; 2015 Oct 11; 26():274-85. PubMed ID: 26300335
    [Abstract] [Full Text] [Related]

  • 10. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
    Li J, Du X, Zheng N, Xu L, Xu J, Li S.
    Colloids Surf B Biointerfaces; 2016 May 01; 141():374-381. PubMed ID: 26878288
    [Abstract] [Full Text] [Related]

  • 11. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W, Guo Z, Zheng K, Ma K, Cui C, Wang L, Yuan Y, Tang Y.
    Int J Pharm; 2017 Dec 20; 534(1-2):71-80. PubMed ID: 28958879
    [Abstract] [Full Text] [Related]

  • 12. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B, Poudel BK, Ruttala HB, Regmi S, Pathak S, Gautam M, Jin SG, Jeong JH, Choi HG, Ku SK, Yong CS, Kim JO.
    Acta Biomater; 2018 Oct 15; 80():364-377. PubMed ID: 30201431
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyaluronic acid modified mesoporous carbon nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Wan L, Jiao J, Cui Y, Guo J, Han N, Di D, Chang D, Wang P, Jiang T, Wang S.
    Nanotechnology; 2016 Apr 01; 27(13):135102. PubMed ID: 26901756
    [Abstract] [Full Text] [Related]

  • 15. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y, Li M, Liu T, Liu J, Xie Y, Zhang J, Xu S, Liu H.
    Int J Nanomedicine; 2019 Apr 01; 14():4029-4044. PubMed ID: 31213813
    [Abstract] [Full Text] [Related]

  • 16. pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery.
    Lin JT, Du JK, Yang YQ, Li L, Zhang DW, Liang CL, Wang J, Mei J, Wang GH.
    Mater Sci Eng C Mater Biol Appl; 2017 Dec 01; 81():478-484. PubMed ID: 28888000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z, He D, He X, Wang K, Yang X, Qing Z, Zhou Q.
    Langmuir; 2013 Oct 15; 29(41):12804-10. PubMed ID: 24073830
    [Abstract] [Full Text] [Related]

  • 20. Using hyaluronic acid-functionalized pH stimuli-responsive mesoporous silica nanoparticles for targeted delivery to CD44-overexpressing cancer cells.
    Wang Z, Tian Y, Zhang H, Qin Y, Li D, Gan L, Wu F.
    Int J Nanomedicine; 2016 Oct 15; 11():6485-6497. PubMed ID: 27980406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.